# Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)

> **NCT03809377** · — · ACTIVE_NOT_RECRUITING · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 25 (actual)

## Conditions studied

- Cancer

## Interventions

- **PROCEDURE:** Blood donation during radiotherapy

## Key facts

- **NCT ID:** NCT03809377
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-05-09
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03809377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03809377, "Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03809377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*